SCHEMBL18565601

SCHEMBL18565601

c1ccc2c(c1)oc1cc(-c3ccc4c(c3)c3ccccc3n4-c3ccc(-c4cc(-c5ccc(-n6c7ccccc7c7cc(-c8ccc9c(c8)oc8ccccc89)ccc76)cc5)nc(-c5ccc6cc(-n7c8ccccc8c8cc(-c9ccc%10c(c9)oc9ccccc9%10)ccc87)ccc6c5)n4)cc3)ccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.35
KDM4E B2RXH2 2/20 0.33
ATM Q13315 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
AHR P35869 1/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
PTGER4 P35408 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
CHEK2 O96017 1/20 0.31
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565595 0.98 HCRTR1 (0.36) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565541 0.95 HCRTR1 (0.36) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565625 0.95 CHEK2 (0.36) KDM4EATML3MBTL1AHRMEN1
SCHEMBL18565594 0.94 HCRTR1 (0.37) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565600 0.93 KDM4E (0.36) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565587 0.93 HCRTR1 (0.38) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565609 0.93 HCRTR1 (0.36) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565598 0.93 HCRTR1 (0.36) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565519 0.93 HCRTR1 (0.37) HCRTR1KDM4EATML3MBTL1AHR
SCHEMBL18565618 0.93 CASP3 (0.35) HCRTR1KDM4EATML3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 HCRTR1 4165/4885KDM4E 225/4885ATM 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.